Navigation Links
Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply
Date:1/11/2008

Statement by Mark Walton, Ph.D., President, ViaGen

January 11, 2008

WASHINGTON, Jan. 11 /PRNewswire-USNewswire/ -- "In light of the European Food Safety Authority's strong endorsement of the safety of food from clones and their offspring, we urge the U.S. Food and Drug Administration to release its final risk assessment at the earliest possible moment and to lift the voluntary moratorium. The international scientific consensus is clear: food from these animals and their offspring is as safe to eat as any other food. The opportunity to increase the availability of exceptional breeding stock offers great benefits to producers and consumers worldwide.

"ViaGen and Trans Ova - the major cloning companies in the U.S. - recently announced a tracking system that will ensure cloned animals are not introduced into the food supply. This supply chain management system was developed with the input of the entire food chain - including major representatives of the beef, pork, dairy, retail and food service industries."

Additional Resources:

Link to EFSA Report: http://tinyurl.com/27lka7

Link to clone tracking information: http://www.clonesafety.org/cloning/scm

Background on International Cloning Regulation:

-- Last year the European Commission (EC) charged the European Food Safety Authority (EFSA) to do a risk assessment of the safety, animal health and environmental concerns; this document was released today.

-- The governments of France and New Zealand have published risk assessments, finding the foods from clones and their offspring to be safe and equivalent.

-- Australia has accepted the New Zealand risk assessment, as they are governed by similar food safety agencies.

-- Japan has developed a risk assessment; the Japanese government is awaiting publication of FDA's final risk assessment before publishing.

-- Argentina has enacted a law permitting the use of biotechnology in agriculture including cloning. Brazil is working on a law to approve the use of cloning in livestock, a move that is necessary to register cloned animals in the breed registries. Cloning activities are underway already in both countries. It is believed that Mexico will await Canada's decision.

-- Commercial cloning research is active in Japan, China, France, Germany, Australia, New Zealand and the United Kingdom. In fact, China has said it plans to build a beef herd equivalent in quality to the U.S. and will use all available technologies including cloning.

About ViaGen, Inc. (http://www.viagen.com): ViaGen adds value to the marketplace by cloning cattle, horses, and pigs; licensing and selling proprietary animal genetics; and providing traits and technology for animal agriculture industries worldwide. The company is based in Austin, Texas.


'/>"/>
SOURCE ViaGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
2. /CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement
3. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
4. Statement of International Dairy Foods Association President and CEO Connie Tipton
5. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
6. Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results
7. CCPM Issues Statement on FDAs GIVE Initiative
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. Statement from GPhA President and CEO Kathleen Jaeger on FDAs Generic Initiative
10. XTL Biopharmaceuticals: AGM/EGM Statements
11. Coherent Announces Restatement Related to Stock-Based Compensation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):